Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
DA32 Life Science Tech Acquisition Corp. quarterly Debt-to-equity history and change rate from Q2 2022 to Q1 2023.
DA32 Life Science Tech Acquisition Corp. Debt-to-equity for the quarter ending 31 Mar 2023 was -140 %.
Debt-to-equity, Quarterly (%)
DA32 Life Science Tech Acquisition Corp. Quarterly Debt-to-equity (%)
Period
Value
YoY Chg
Change %
Date
Q1 2023
-140
31 Mar 2023
Q4 2022
-145
31 Dec 2022
Q3 2022
-0.7
30 Sep 2022
Q2 2022
-0.69
30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.